Jeonjinbio Co. Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.03x

Jeonjinbio Co. Ltd capital reinvestment ratio. Jeonjinbio Co. Ltd (110020) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩313.21 Million) in capital expenditures (₩10.04 Million). Check Jeonjinbio Co. Ltd (110020) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

₩313.21 Million
KRW

Capital Expenditures

₩10.04 Million
KRW

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Jeonjinbio Co. Ltd (2024–2024)

Capital reinvestment ratio of Jeonjinbio Co. Ltd from 2024 to 2024. This chart tracks Jeonjinbio Co. Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore 110020 net asset momentum to track the company's year-over-year net asset growth rate.

Jeonjinbio Co. Ltd Capital Reinvestment Ratio by Year (2024–2024)

Jeonjinbio Co. Ltd capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see Jeonjinbio Co. Ltd cash conversion from operations.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.13x ₩3.01 Billion ₩394.36 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow